Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
American Strategic Investment posts Q1 lossKNDS proceeds with IPO prep despite delay rumorsNew rule for gifts to customs officialsCitizens Reiterates Uber Stock Rating on EBITDABT Group explores sale or partnership for international unitBaku professor undergoes clinical deathJefferies Raises AMAT Target to $510 on AICitizens Reiterates Charles Schwab Stock RatingARTI explains different passing scoresBofA hikes Applied Materials target to $540American Strategic Investment posts Q1 lossKNDS proceeds with IPO prep despite delay rumorsNew rule for gifts to customs officialsCitizens Reiterates Uber Stock Rating on EBITDABT Group explores sale or partnership for international unitBaku professor undergoes clinical deathJefferies Raises AMAT Target to $510 on AICitizens Reiterates Charles Schwab Stock RatingARTI explains different passing scoresBofA hikes Applied Materials target to $540
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#aardvark-therapeutics

Latest news and interesting information about aardvark-therapeutics.

Morgan Stanley Downgrades Aardvark Stock
Today / 08:32
|
977

Morgan Stanley Downgrades Aardvark Stock

Morgan Stanley downgrades Aardvark Therapeutics stock to Underweight, price target $3, after FDA clinical hold on ARD-101 over safety concerns.

ANALYST RATINGS →
0
...